Lidomax by Oncora Pharma, LLC LIDOMAX gel

Lidomax by

Drug Labeling and Warnings

Lidomax by is a Prescription medication manufactured, distributed, or labeled by Oncora Pharma, LLC. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

DESCRIPTION

Lidomax™ is a topical gel containing Lidocaine Hydrochloride 2%, a local anesthetic. It is intended for topical application to intact skin.

INDICATIONS AND USAGE

Lidomax™ is indicated for topical analgesia as directed by a healthcare provider.

WARNINGS

For external use only. Not for ophthalmic use. Avoid contact with eyes. Do not use if allergic to lidocaine or any components of the formulation. Keep out of reach of children.

DOSAGE AND ADMINISTRATION

Apply a thin layer to the affected area 3 to 4 times daily or as directed by a healthcare provider. For external use only.

HOW SUPPLIED

Lidomax™ (Lidocaine HCl 2%) is supplied as a clear topical gel in a 3 oz (85 g) tube.  NDC: 85477-304-07

PRINCIPAL DISPLAY PANEL

Store at 25°C (77°F); excursions permitted to 15°–30°C (59°–86°F).
[See USP Controlled Room Temperature].
Keep container tightly closed.

pdp

INGREDIENTS AND APPEARANCE

LIDOMAX 
lidomax gel

Product Information
Product Type	HUMAN PRESCRIPTION DRUG	Item Code (Source)	NDC: 85477-304
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
LIDOCAINE (UNII: 98PI200987) (LIDOCAINE - UNII:98PI200987)	LIDOCAINE	20 mg  in 1 g

Inactive Ingredients
Ingredient Name	Strength
WATER (UNII: 059QF0KO0R)
HYDROXYETHYLCELLULOSE (UNII: T4V6TWG28D)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)
SODIUM HYDROXIDE (UNII: 55X04QC32I)
LACTIC ACID (UNII: 33X04XA5AT)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 85477-304-07	85 g in 1 BOTTLE, PUMP; Type 0: Not a Combination Product	02/26/2026

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
unapproved drug other		02/26/2026

Labeler - Oncora Pharma, LLC (119482542)